Immunoblot revealed that AKT was enhanced by two phosphorylation sites (Thr308 and Ser473) of which MSI1-overexpressed GBM cells were significantly sensitive than that of Flag-control cells in a dose-dependent manner (Figure 3A and 3B). This evidence concerns the gene MSI1 and glioblastoma.